Grifols, the Spanish biotech firm, has taken a 20 percent stake in a California- based laboratory for $50 million. The deal is among the latest involving overseas businesses taking stakes in laboratories in the United States, or vice versa. .In exchange for the cash infusion, Grifols will have an exclusive license to use Singulex, Inc.’s…
Grifols Takes 20 percent Stake in Singulex
Grifols, the Spanish biotech firm, has taken a 20 percent stake in a California- based laboratory for $50 million. The deal is among the latest involving overseas businesses taking stakes in laboratories in the United States, or vice versa. .In exchange for the cash infusion, Grifols will have an exclusive license to use Singulex, Inc.’s […]